SG3 Management, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 312 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2021$1,806,000
+2.6%
132,500
+23.3%
0.04%
-30.2%
Q3 2021$1,761,000
-2.7%
107,5000.0%0.05%
-17.2%
Q2 2021$1,809,000
-7.8%
107,5000.0%0.06%
+30.6%
Q1 2021$1,963,000
+2057.1%
107,500
+2050.0%
0.05%
+2350.0%
Q4 2020$91,000
+2.2%
5,0000.0%0.00%
-33.3%
Q3 2020$89,000
-1.1%
5,0000.0%0.00%
-50.0%
Q2 2020$90,000
-96.0%
5,000
-95.5%
0.01%
-97.3%
Q1 2019$2,272,000111,5500.22%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders